Business Standard

Monday, December 23, 2024 | 06:15 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

India to increase Covaxin production to 100 mn doses per month by Sept

Currently, 10 mn doses of the indigenous coronavirus vaccine are being produced every month, says govt

Covaxin
Premium

Covaxin (Photo: Bloomberg)

BS Web Team
At a time when India is grappling with second wave of coronavirus, the union government on Friday announced manifold increase in production capacity of Covaxin in the coming months.

The production capacity is expected to reach nearly 100 million doses per month by September 2021 from the existing 10 million doses. 

"Government of India is providing financial support as grant to vaccine manufacturing facilities for enhanced production capacities. The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021 i.e increasing the production from 10 million vaccine

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in